Together, our recent finding that microglia-derived OLFML3 promotes malignant features of glioma cells, coupled with the general angiogenic effects of OLFML3, prompt us to speculate that microglia-derived OLFML3 may also promote EC neoangiogenesis in GBM. The gene discussed is OLFML3; the disease is glioma.